A Phase I/II Study to Assess the Safety and Efficacy of Pazopanib and Pembrolizumab Combination Therapy in Patients with Advanced Renal Cell Carcinoma
Simon Chowdhury, J. Infante, Robert D. Hawkins, Martin H. Voss, Rodolfo F. Perini, Tobias Arkenau, Mark Voskoboynik, Paola Aimone, Naëije Isabelle, Albert Reising, David F. McDermott
Topics & Concepts
PazopanibMedicinePembrolizumabRenal cell carcinomaOncologyInternal medicineKidney cancerCancerImmunotherapySunitinibRenal cell carcinoma treatmentCancer Immunotherapy and BiomarkersFerroptosis and cancer prognosis